Aktie 4737 BIONIME CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Bionime Corporation

Aktien

4737

TW0004737002

4737

Schlusskurs Taiwan S.E.
Andere Börsenplätze
 00:00:00 03.05.2024 		% 5 Tage % 1. Jan.
68 TWD -0.44% Intraday Chart für Bionime Corporation -1.16% -9.09%
15.03. Bionime Corporation meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Bionime Corporation meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Bionime Corporation Announces Dividend for the Year Ended December 31, 2023
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Bionime Corporation Announces TFDA Approval for iFree Continuous Glucose Monitoring System Second-Class Medical Device License
Bionime Corporation Announces Resignation of Marvin Wu as Globle Sales Division Officer
Bionime Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Bionime Corporation Announces Appointment of Aling Lai as New Member to the Remuneration Committee
Bionime Corporation Appoints Aling Lai as Additional Member of Audit Committee
Bionime Corporation Approves Cash Dividends, Payable on August 18, 2023
Bionime Corporation Announces Election of Aling Lai as an Additional Independent Director
Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Bionime Corporation Revises Cash Dividend for 2022
Bionime Corporation Appoints Chen Hui-Zhen as Corporate Governance Officer
Bionime Corporation Announces Cash Dividend for 2022
Bionime Corporation Announces Resignation of Tai,Tsung-Kai as Institutional Director, Effective April 30, 2023
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Bionime Corporation Approves the Factory Area to Expand Building the Clean Room to Accommodate Production Equipment and Increase Production Capacity
Bionime Announces the Introduction of Its Revolutionary iFree CGM for Diabetes Management Coming Soon
Bionime Corporation to Launch the Rightest iFree CGM, Proposed to Offer Precise and Accurate Blood Glucose Measurement and Monitoring
Bionime RIGHTEST iFree CGM System - An Innovative Approach to Keep Track of Every One Health
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 4737 Aktie
  4. Nachrichten Bionime Corporation
  5. Andere Sprachen